StockData
Vivani Medical, Inc. logo

Vivani Medical, Inc. (VANI) stock

VANINasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$1.01+0.03 (+2.70%)

Close on Nov 13, 2026Market cap $91.11MP/E –Yield –

Vivani Medical ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Vivani Medical's ebitda for the twelve months ending Mar 31, 2026 was -$27.36M. For fiscal 2025 it was -$27.13M. The highest annual figure on record is -$12.98M in fiscal 2021.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$27.13M–
FY2024Dec 31, 2024-$24.28M–
FY2023Dec 31, 2023-$26.61M–
FY2022Dec 31, 2022-$20.86M–
FY2021Dec 31, 2021-$12.98M–
FY2020Dec 31, 2020-$14.73M–
FY2019Dec 31, 2019-$33.56M–
FY2018Dec 31, 2018-$34.75M–
FY2017Dec 31, 2017-$28.15M–
FY2016Dec 31, 2016-$32.78M–
FY2015Dec 31, 2015-$19.71M–
FY2014Dec 31, 2014-$20.95M–
FY2013Dec 31, 2013-$17.68M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$7.40M–
Q1 FY2026Mar 31, 2026-$6.69M–
Q4 FY2025Dec 31, 2025-$6.69M–
Q3 FY2025Sep 30, 2025-$6.62M–
Q2 FY2025Jun 30, 2025-$7.36M–
Q1 FY2025Mar 31, 2025-$6.46M–
Q4 FY2024Dec 31, 2024-$6.37M–
Q3 FY2024Sep 30, 2024-$6.20M–
Q2 FY2024Jun 30, 2024-$5.58M–
Q1 FY2024Mar 31, 2024-$6.13M–
Q4 FY2023Dec 31, 2023-$6.12M–
Q3 FY2023Sep 30, 2023-$7.07M–
Q2 FY2023Jun 30, 2023-$6.92M–
Q1 FY2023Mar 31, 2023-$6.49M–
Q4 FY2022Dec 31, 2022-$7.68M–
Q3 FY2022Sep 30, 2022-$5.34M–
Q2 FY2022Jun 30, 2022-$4.00M–
Q1 FY2022Mar 31, 2022-$3.82M–
Q4 FY2021Dec 31, 2021-$1.21M–
Q3 FY2021Sep 30, 2021-$3.26M–
Q2 FY2021Jun 30, 2021-$2.28M–
Q1 FY2021Mar 31, 2021-$2.82M–
Q4 FY2020Dec 31, 2020-$1.26M–
Q3 FY2020Sep 30, 2020-$1.58M–
Q2 FY2020Jun 30, 2020-$3.10M–
Q1 FY2020Mar 31, 2020-$8.80M–
Q4 FY2019Dec 31, 2019-$8.02M–
Q3 FY2019Sep 30, 2019-$7.52M–
Q2 FY2019Jun 30, 2019-$8.34M–
Q1 FY2019Mar 31, 2019-$9.67M–
Q4 FY2018Dec 31, 2018-$8.77M–
Q3 FY2018Sep 30, 2018-$8.44M–
Q2 FY2018Jun 30, 2018-$7.88M–
Q1 FY2018Mar 31, 2018-$9.66M–
Q4 FY2017Dec 31, 2017-$7.32M–
Q3 FY2017Sep 30, 2017-$6.63M–
Q2 FY2017Jun 30, 2017-$6.76M–
Q1 FY2017Mar 31, 2017-$7.44M–
Q4 FY2016Dec 31, 2016-$10.26M–

More Vivani Medical figures

See a number that looks wrong?